These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 16774488)
1. The challenge of effectively communicating patient safety information. Hugman B; Edwards IR Expert Opin Drug Saf; 2006 Jul; 5(4):495-9. PubMed ID: 16774488 [TBL] [Abstract][Full Text] [Related]
2. Physicians' perspectives on communicating prescription drug information. McGrath JM Qual Health Res; 1999 Nov; 9(6):731-45. PubMed ID: 10662256 [TBL] [Abstract][Full Text] [Related]
3. The practicing clinician and regulatory safety concerns. McAllister RG; Franson T; Kraus CN Curr Drug Saf; 2013 Feb; 8(1):17-24. PubMed ID: 23656444 [TBL] [Abstract][Full Text] [Related]
4. Effects of FDA safety warnings may vary. Kuehn BM JAMA; 2012 Mar; 307(9):894-5. PubMed ID: 22396504 [No Abstract] [Full Text] [Related]
5. Consumer Understanding, Preferences, and Responses to Different Versions of Drug Safety Messages in the United States: A Randomized Controlled Trial. McCormack L; Craig Lefebvre R; Bann C; Taylor O; Rausch P Drug Saf; 2016 Feb; 39(2):171-84. PubMed ID: 26547718 [TBL] [Abstract][Full Text] [Related]
6. Off-label and unlicensed prescribing for children: have we made any progress? Waller DG Br J Clin Pharmacol; 2007 Jul; 64(1):1-2. PubMed ID: 17577389 [No Abstract] [Full Text] [Related]
7. The Erice Manifesto: for global reform of the safety of medicines in patient care. Drug Saf; 2007; 30(3):187-90. PubMed ID: 17343426 [TBL] [Abstract][Full Text] [Related]
8. Risk communication of vaccines: challenges in the post-trust environment. Bouder F Curr Drug Saf; 2015; 10(1):9-15. PubMed ID: 25859669 [TBL] [Abstract][Full Text] [Related]
9. [Making Patient-focused Information Provision a Reality: One Company's Approach]. Takemoto S Yakugaku Zasshi; 2018; 138(3):315-323. PubMed ID: 29503422 [TBL] [Abstract][Full Text] [Related]
10. Labelling and 'Dear Doctor' letters: are they noncommittal? van Grootheest AC; Edwards IR Drug Saf; 2002; 25(15):1051-5. PubMed ID: 12452731 [TBL] [Abstract][Full Text] [Related]
11. Safety and risk communication to patients. Thürmann PA Expert Opin Drug Saf; 2006 Nov; 5(6):747-50. PubMed ID: 17044801 [TBL] [Abstract][Full Text] [Related]
12. Manufacturing uncertainty: adverse effects of drug development for women. Peppin P Int J Law Psychiatry; 2003; 26(5):515-32. PubMed ID: 14522223 [No Abstract] [Full Text] [Related]
13. Public pharmacovigilance communication: a process calling for evidence-based, objective-driven strategies. Bahri P Drug Saf; 2010 Dec; 33(12):1065-79. PubMed ID: 21077698 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacists contribute to the safety of medicines]. Nishihara S Yakugaku Zasshi; 2011; 131(6):865-9. PubMed ID: 21628969 [TBL] [Abstract][Full Text] [Related]
16. Recognition and Knowledge of Medications with Black Box Warnings Among Pediatricians and Emergency Physicians. Smollin CG; Fu J; Levin R J Med Toxicol; 2016 Jun; 12(2):180-4. PubMed ID: 26553279 [TBL] [Abstract][Full Text] [Related]
17. Pharmacovigilance and communicating safety information. Drug Ther Bull; 2012 Dec; 50(12):138-40. PubMed ID: 23241564 [TBL] [Abstract][Full Text] [Related]
18. Adverse drug reaction processing in the United States and its dependence on physician reporting: zomepirac (Zomax) as a case in point. Corre KA; Spielberg TE Ann Emerg Med; 1988 Feb; 17(2):145-9. PubMed ID: 3257365 [TBL] [Abstract][Full Text] [Related]
19. Pediatric Off-Label and Unlicensed Drug Use and Its Implications. Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168 [TBL] [Abstract][Full Text] [Related]
20. Editorial: Communicating vaccine safety - the Vienna Vaccine Safety Initiative. Rath B Curr Drug Saf; 2015; 10(1):3-4. PubMed ID: 25859667 [No Abstract] [Full Text] [Related] [Next] [New Search]